Get Ready for the RVO Revolution
By:  Arsham Sheybani, MD; Rajendra S. Apte, MD, PhD
Injectable therapies move to the forefront, greatly expanding the options for clinicians

Considering the Options for RVO Therapy
By:  John A Wells, III, MD; John J. Wroblewski, MD

Peer-reviewed: Intraocular Inflammatory Disorders Update
By:  Olga M. Ceron, MD; David M. Hinkle, MD; C. Stephen Foster, MD, FACS, FACR, FAAO

A Safety Net for Retinopathy of Prematurity Management
By:  Lawrence Y. Ho, MD; Lisa J. Faia, MD; Michael T. Trese, M.D.
New Web-based initiative could expand access to pediatric retina specialists nationwide

RPS Recap: Exhibition of Inhibition
By:  Andrew E. Mathis, PhD, Medical Editor
The final article in our series recapping research presented at our annual meeting

Putting “Management” Into Risk Management
By:  Leslie Goldberg, Associate Editor
Proactive policies for keeping patients safe

Bringing Combined Procedures Into the Mainstream
By:  Robert A. Sisk, MD; Timothy G. Murray, MD, MBA

Posterior-segment Complications of Keratorefractive Surgery
By:  Stephen G. Schwartz, MD, MBA; Thomas A. Albini , MD; Harry W. Flynn, Jr., MD

Short-pulse Laser Treatment: Redefining Retinal Treatment
By:  Daniel Palanker, PhD; Yannis M. Paulus, MD; Mark S. Blumenkranz, MD
Minimizing side effects without compromising care

Controversies in the Long-term Management of Neovascular AMD
By:  Scott W. Cousins, MD
The role of imaging in clinical decision making

Case Report
By:  Chirag P. Shah, MD, MPH
Massive Papilledema due to Hydrocephalus

Special section sponsored by Alcon
By:  Sunil Gupta, MD; Alan Franklin, MD, PhD; John P. Myers, MD
Reusables vs. Disposables: A Safe Conclusion for DSPs

Upfront
From the editor-in-chief

Subspecialty News
By:  Jerry Helzner, Senior Editor; Leslie Goldberg, Associate Editor; Andrew E. Mathis, PhD, Medical Editor
Sustained-release Lucentis; TADRS; PVD

Journal Club
Recent noteworthy studies to stimulate debate

Coding Q&A
By:  Riva Lee Asbell
Medicare consultation codes no longer used

Clinical Trial Spotlight
By:  Andrew E. Mathis, PhD, Medical Editor
Genzyme tests viral vector for wet AMD

Clinical Trials Update

Products & Services

Calendar

Focus On
By:  Leslie Goldberg, Associate Editor
Patient-tailored Retina Treatments Could Improve Safety and Predictability